Evidence map›Paper›PMID 36145091›Full record

ArticleNutrients2022

Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments.

Premranjan Kumar, Jayshree Mishra, Narendra Kumar

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Therapeutic Candidates for Alzheimer's Disease: Saponins.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Premranjan KumarDepartment of Pharmaceutical Sciences, ILR College of Pharmacy Texas A&M Health Science Center, Kingsville, TX 78363, USA.
Jayshree MishraDepartment of Pharmaceutical Sciences, ILR College of Pharmacy Texas A&M Health Science Center, Kingsville, TX 78363, USA.
Narendra KumarDepartment of Pharmaceutical Sciences, ILR College of Pharmacy Texas A&M Health Science Center, Kingsville, TX 78363, USA.ORCID 0000-0002-1193-0954
Texas A&M Health Science Center · US

Funding

Development of a Novel ELISA Kit for Screening Potential JAK3 InhibitorsR43GM109528 · NIGMS · 21ST CENTURY THERAPEUTICS, INC. · PI SHAW, JIAJIU · 2014 to 2015
$674k
NIGMS NIH HHS R43 GM109528NIH HHS GM1105
6 · The paper itself

Abstract

BACKGROUND AND

aimsA compromise in intestinal mucosal functions is associated with several chronic inflammatory diseases. Previously, we reported that obese humans have a reduced expression of intestinal Janus kinase-3 (Jak3), a non-receptor tyrosine kinase, and a deficiency of Jak3 in mice led to predisposition to obesity-associated metabolic syndrome. Since meta-analyses show cognitive impairment as co-morbidity of obesity, the present study demonstrates the mechanistic role of Jak3 in obesity associated cognitive impairment. Our data show that high-fat diet (HFD) suppresses Jak3 expression both in intestinal mucosa and in the brain of wild-type mice. METHODOLOGY: Recapitulating these conditions using global (Jak3-KO) and intestinal epithelial cell-specific conditional (IEC-Jak3-KO) mice and using cognitive testing, western analysis, flow cytometry, immunofluorescence microscopy and 16s rRNA sequencing, we demonstrate that HFD-induced Jak3 deficiency is responsible for cognitive impairments in mice, and these are, in part, specifically due to intestinal epithelial deficiency of Jak3.

resultsWe reveal that Jak3 deficiency leads to gut dysbiosis, compromised TREM-2-functions-mediated activation of microglial cells, increased TLR-4 expression and HIF1-α-mediated inflammation in the brain. Together, these lead to compromised microglial-functions-mediated increased deposition of β-amyloid (Aβ) and hyperphosphorylated Tau (pTau), which are responsible for cognitive impairments. Collectively, these data illustrate how the drivers of obesity promote cognitive impairment and demonstrate the underlying mechanism where HFD-mediated impact on IEC-Jak3 deficiency is responsible for Jak3 deficiency in the brain, reduced microglial TREM2 expression, microglial activation and compromised clearance of Aβ and pTau as the mechanism during obesity-associated cognitive impairments.

conclusionThus, we not only demonstrate the mechanism of obesity-associated cognitive impairments but also characterize the tissue-specific role of Jak3 in such conditions through mucosal tolerance, gut-brain axis and regulation of microglial functions.

Indexed as

Cognitive DysfunctionToll-Like Receptor 4AnimalsDiet, High-FatHumansJanus Kinase 3Membrane GlycoproteinsMiceMice, Inbred C57BLObesityReceptors, ImmunologicRNA, Ribosomal, 16SJAK3 protein, humanJanus Kinase 3Membrane GlycoproteinsReceptors, ImmunologicRNA, Ribosomal, 16SToll-Like Receptor 4Trem2 protein, mousecognitive impairmentshigh-fat dietJanus kinase-3microgliaobesityTREM-2

Identifiers

PMID36145091
PMCPMC9505565
OpenAlexW4296021739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.